Table 2 Treatment
From: Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
Radiotherapy (RT) | Â |
|---|---|
   Median total dose (range) | 60 (48-60) |
   Median number of fractions (range) | 30 (24-33) |
Chemotherapy (CT) | Â |
   · CT concomitant with RT | 65 (100) |
   Total number of cycles delivered | 417 |
   Median number of cycles delivered (range) | 7 (2-8) |
   · Adjuvant CT (post RT) | 56 (86) |
   Total number of cycles delivered | 343 |
   Median number of cycles delivered (range) | 6 (1-12) |
Treatment status | N (%) |
   Completed | 31(48) |
   Discontinuation | 34(52) |
PD | 19(29) |
Death | 5(8) |
Toxicity (non fatal) | 5(8) |
Refused to continue | 4(6) |
Clinical deterioration | 1(2) |